Cite
[Attention deficit hyperactivity disorder with comorbid anxiety disorders: pharmacotherapy options]
MLA
N N, Zavadenko, and Solomasova A A. “[Attention Deficit Hyperactivity Disorder with Comorbid Anxiety Disorders: Pharmacotherapy Options].” Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova, vol. 112, no. 8, Oct. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........9d8bc55ed70696d1e771250e388aeda5&authtype=sso&custid=ns315887.
APA
N N, Z., & A A, S. (2012). [Attention deficit hyperactivity disorder with comorbid anxiety disorders: pharmacotherapy options]. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova, 112(8).
Chicago
N N, Zavadenko, and Solomasova A A. 2012. “[Attention Deficit Hyperactivity Disorder with Comorbid Anxiety Disorders: Pharmacotherapy Options].” Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 112 (8). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........9d8bc55ed70696d1e771250e388aeda5&authtype=sso&custid=ns315887.